(Sharecast News) - Niox Group reported strong trading in the first four months of 2025 on Wednesday, with group sales rising 21% year-on-year, supported by continued momentum in its clinical business and a sharp increase in research revenues.
The AIM-traded company, which was holding its annual general meeting in Oxford, said...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE